Dr. Emily Fox comes to Stanford from the University of Washington where she has held the post of Amazon Professor of Machine Learning in the Paul G. Allen School of Computer Science & Engineering and Department of Statistics. Since 2018, Emily has led the Health AI team at Apple where she is a Distinguished Engineer. Prior to joining UW, Emily was an Assistant Professor at the Wharton School Department of Statistics at the University of Pennsylvania.

Dr. Daniel E. Ho is the William Benjamin Scott and Luna M. Scott Professor of Law at Stanford Law School, Professor of Political Science, and Senior Fellow at the Stanford Institute for Economic Policy Research. He is also Associate Director of the Stanford Institute for Human-Centered Artificial Intelligence and Director of the Regulation, Evaluation, and Governance Lab (RegLab).  With the RegLab, he has engaged in questions surrounding device regulation, regulation of machine learning products, and health policy.

Dr. Kavita Sarin, M.D./ Ph.D., is an Associate Professor of Dermatology. She has an academic interest in Precision Medicine, focused on the integration of genetic and clinical patient data to inform disease susceptibility, stratify prognosis, and direct treatments in dermatologic disease. Her lab applied cutting edge sequencing and imaging technologies to better understand skin cancer and rare immunologic skin diseases. She sees patients in medical dermatology at Portola Valley and directs a specialized Skin Cancer Genetics clinic.

Dr. Sarin's research encompasses two main areas:

Dr. Allison W. Kurian, M.D., M.Sc. is a Professor of Medicine and of Epidemiology and Population Health at Stanford University School of Medicine. She received her medical degree from Harvard Medical School, trained as an intern and resident in Internal Medicine at the Massachusetts General Hospital, and completed her fellowship training in Medical Oncology along with a master’s degree in Epidemiology at Stanford University.

Dr. Carolyn Rodriguez is Associate Dean for Academic Affairs, Stanford University School of Medicine, Associate Chair for Inclusion and Diversity in the Department of Psychiatry and Behavioral Sciences at Stanford University, and a Consultation-Liaison Psychiatrist at the Palo Alto Veterans Affairs. As the Director of the Translational Therapeutics Lab and Associate Professor in the Department of Psychiatry and Behavioral Sciences, Dr. Rodriguez leads studies investigating the brain basis of severe mental disorders.

Dr. Todd P. Coleman is an Associate Professor in the Department of Bioengineering, and by courtesy, Electrical Engineering at Stanford University. He received B.S. degrees in electrical engineering (summa cum laude), as well as computer engineering (summa cum laude) from the University of Michigan. He received M.S. and Ph.D. degrees from MIT in electrical engineering and computer science. He did postdoctoral studies at MIT and Mass General Hospital in quantitative neuroscience.

Dr. Gen Shinozaki's research interests include investigation epigenetics mechanism of delirium pathophysiology, neuroinflammation and aging using human and mouse samples. Dr. Shinozaki's group aims to develop epigenetic biomarkers for delirium to predict, detect and monitor illness course, treatment response and patient outcomes. They are also working on a small point-of-care EEG device to detect delirium and predict patient outcome.